BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20108308)

  • 1. Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?
    Wang T; Nelson RA; Bogardus A; Grannis FW
    Cancer; 2010 Mar; 116(6):1518-25. PubMed ID: 20108308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
    Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
    Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
    Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
    Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ; Curran WJ; Keller SM; Catalano RB; Litwin S; Blankstein KB; Haas N; Campli SN; Comis RL
    Cancer J Sci Am; 1996; 2(2):99-105. PubMed ID: 9166507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survivors in stage IV non-small cell lung cancer.
    Okamoto T; Maruyama R; Shoji F; Asoh H; Ikeda J; Miyamoto T; Nakamura T; Miyake T; Ichinose Y
    Lung Cancer; 2005 Jan; 47(1):85-91. PubMed ID: 15603858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease.
    Laurie SA; Kris MG; Portlock CS; Rosenzweig KE; Miller VA; Krug LM; Rusch VW
    Cancer; 2002 Jul; 95(1):119-26. PubMed ID: 12115325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial.
    Eberhardt W; Stamatis G; Stuschke M; Wilke H; Müller MR; Kolks S; Flasshove M; Schütte J; Stahl M; Schlenger L; Budach V; Greschuchna D; Stüben G; Teschler H; Sack H; Seeber S
    Br J Cancer; 1999 Dec; 81(7):1206-12. PubMed ID: 10584883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA; Bernardo P; Johnson DH; Schiller JH
    Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)].
    Eberhardt W
    Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
    Zell JA; Ou SH; Ziogas A; Anton-Culver H
    Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural effusion as a significant prognostic factor in non-small cell lung cancer.
    Naito T; Satoh H; Ishikawa H; Yamashita YT; Kamma H; Takahashi H; Ohtsuka M; Hasegawa S
    Anticancer Res; 1997; 17(6D):4743-6. PubMed ID: 9494600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of non-small-cell lung cancer: the Chinese experience in a general teaching hospital.
    Chen YM; Chao JY; Tsai CM; Shiau CY; Liang MJ; Yen SH; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):459-66. PubMed ID: 10925536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.